NAFLD/NASH is associated with a decrease in the secretion of TGs, synthesis of apolipoprotein B-100 and import and export of VLDLs [45], which may also explain why circulating triglycerides in HSD mice were no different to controls. This evidence concerns the gene APOB and metabolic dysfunction-associated steatohepatitis.